Evaluating a targeted Palbociclib-Trastuzumab loaded smart niosome platform for treating HER2 positive breast cancer cells-Reference-Cited by-同舟云学术

Evaluating a targeted Palbociclib-Trastuzumab loaded smart niosome platform for treating HER2 positive breast cancer cells

Published:2024-06 Issue: Volume:7 Page:100237
ISSN:2590-1567
Container-title:International Journal of Pharmaceutics: X
language:en
Short-container-title:International Journal of Pharmaceutics: X

Author:

Saharkhiz Shaghayegh,Nasri Negar,Naderi Nazanin,Dini Ghasem,Ghalehshahi Saeid Shirzadi,Firoozbakht Fateme

Funder

University of Isfahan

Publisher

Elsevier BV

Reference69 articles.

1. A phase II study of palbociclib plus letrozole plus trastuzumab as neoadjuvant treatment for clinical stages II and III ER+ HER2+ breast cancer (PALTAN). Npj;Ademuyiwa;Breast Cancer,2023

2. A phase II study of palbociclib plus letrozole plus trastuzumab as neoadjuvant treatment for clinical stages II and III ER+ HER2+ breast cancer (PALTAN);Ademuyiwa;npj Breast Cancer,2023

3. An overview of active and passive targeting strategies to improve the nanocarriers efficiency to tumour sites;Attia;J. Pharm. Pharmacol.,2019

4. Cellular uptake and relative efficiency in cell inactivation by photo activated sulfonated meso-tetraphenylporphines;Berg;Photochem. Photobiol.,1990

5. Quantum dot-based nanotools for bioimaging, diagnostics, and drug delivery;Bilan;ChemBioChem,2016

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antibacterial and antibiofilm activities of selenium nanoparticles-antibiotic conjugates against anti-multidrug-resistant bacteria;International Journal of Pharmaceutics;2024-06

2. Quantum Dot Research in Breast Cancer: Challenges and Prospects;Materials;2024-05-04